BIOMAT Database Logo BIOMAT Database Logo

Paricalcitol, calcitriol, and survival of patients undergoing hemodialysis. 2003

Shobha Ratnam, and Dinkar Kaw, and Panduranga Rao

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D002117 Calcitriol The physiologically active form of vitamin D. It is formed primarily in the kidney by enzymatic hydroxylation of 25-hydroxycholecalciferol (CALCIFEDIOL). Its production is stimulated by low blood calcium levels and parathyroid hormone. Calcitriol increases intestinal absorption of calcium and phosphorus, and in concert with parathyroid hormone increases bone resorption. 1 alpha,25-Dihydroxycholecalciferol,1 alpha,25-Dihydroxyvitamin D3,1, 25-(OH)2D3,1,25(OH)2D3,1,25-Dihydroxycholecalciferol,1,25-Dihydroxyvitamin D3,1 alpha, 25-dihydroxy-20-epi-Vitamin D3,1,25(OH)2-20epi-D3,1,25-dihydroxy-20-epi-Vitamin D3,20-epi-1alpha,25-dihydroxycholecaliferol,Bocatriol,Calcijex,Calcitriol KyraMed,Calcitriol-Nefro,Decostriol,MC-1288,MC1288,Osteotriol,Renatriol,Rocaltrol,Silkis,Sitriol,Soltriol,Tirocal,1 alpha,25 Dihydroxyvitamin D3,1,25 Dihydroxycholecalciferol,1,25 Dihydroxyvitamin D3,1,25 dihydroxy 20 epi Vitamin D3,Calcitriol Nefro,D3, 1 alpha,25-Dihydroxyvitamin,D3, 1,25-Dihydroxyvitamin,D3, 1,25-dihydroxy-20-epi-Vitamin,KyraMed, Calcitriol,MC 1288
D004872 Ergocalciferols Derivatives of ERGOSTEROL formed by ULTRAVIOLET RAYS breaking of the C9-C10 bond. They differ from CHOLECALCIFEROL in having a double bond between C22 and C23 and a methyl group at C24. Calciferols,Vitamin D 2,Ergocalciferol,Vitamin D2,D2, Vitamin
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D044383 Black People Persons having origins in any of the black racial groups of AFRICA. Note that OMB category BLACK OR AFRICAN AMERICAN is available for the United States population groups. Race and ethnicity terms, as used in the federal government, are self-identified social construct and may include terms outdated and offensive in MeSH to assist users who are interested in retrieving comprehensive search results for studies such as in longitudinal studies. African Continental Ancestry Group,Black Person,Negroid Race,Black Peoples,Black Persons,Negroid Races,People, Black,Person, Black,Persons, Black,Race, Negroid

Related Publications

Shobha Ratnam, and Dinkar Kaw, and Panduranga Rao
Paricalcitol, calcitriol, and survival of patients undergoing hemodialysis.
November 2003, The New England journal of medicine,
Shobha Ratnam, and Dinkar Kaw, and Panduranga Rao
Paricalcitol, calcitriol, and survival of patients undergoing hemodialysis.
November 2003, The New England journal of medicine,
Shobha Ratnam, and Dinkar Kaw, and Panduranga Rao
Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy.
July 2003, The New England journal of medicine,
Shobha Ratnam, and Dinkar Kaw, and Panduranga Rao
Paricalcitol as compared with calcitriol in patients undergoing hemodialysis.
July 2003, The New England journal of medicine,
Shobha Ratnam, and Dinkar Kaw, and Panduranga Rao
Paricalcitol versus calcitriol treatment for hyperparathyroidism in pediatric hemodialysis patients.
October 2006, Pediatric nephrology (Berlin, Germany),
Shobha Ratnam, and Dinkar Kaw, and Panduranga Rao
Association between calcitriol and paricalcitol with oxidative stress in patients with hemodialysis.
June 2021, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition,
Shobha Ratnam, and Dinkar Kaw, and Panduranga Rao
Comparison of erythropoietin resistance in hemodialysis patients using calcitriol, cinacalcet, or paricalcitol.
November 2015, Journal of clinical pharmacology,
Shobha Ratnam, and Dinkar Kaw, and Panduranga Rao
Differential effects of paricalcitol and calcitriol on intestinal calcium absorption in hemodialysis patients.
January 2010, American journal of nephrology,
Shobha Ratnam, and Dinkar Kaw, and Panduranga Rao
Suppression of parathyroid hormone secretion in hemodialysis patients: comparison of paricalcitol with calcitriol.
November 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation,
Shobha Ratnam, and Dinkar Kaw, and Panduranga Rao
Efficacy and safety of paricalcitol in patients undergoing hemodialysis: a meta-analysis.
January 2019, Drug design, development and therapy,
Copied contents to your clipboard!